Social networks
362 2,072Entity types
Location
555 Pine St, San Francisco, CA 94108, USA
San Francisco
United States of America
Employees
Scale: 2-10
Estimated: 15
Engaged corporates
2Added in Motherbase
1 year, 3 months agoInvesting Where Biology and Technology Converge
Genoa Ventures invests in early-stage companies innovating at the convergence of biology and technology.
Visionary startups developing innovative life science technologies with outsized potential often struggle to raise capital from traditional funders. These companies are typically multi-disciplinary (e.g. genomics + optics + microfluidics + big data) and/or market-making, and don't neatly fit most VC’s patterns and boxes.
Genoa Ventures stands in this gap. Genoa Ventures uniquely combines an appetite for technology-driven, “category-defying” opportunities in life sciences with the domain expertise and operational experience necessary to select and nurture the best bio-based companies early, before most other investors. We take the time to understand the science and technology, applications and markets, and to help these companies achieve their full potential.
We believe in the enormous and relatively untapped possibilities of life science technologies and discoveries applied to realms outside of healthcare, and in the unbounded potential of the entrepreneurial visionaries who will lead us in realizing these possibilities.
synthetic biology, genomics, genetics, research tools, venture capital, Seed, Series A, diagnostics, agriculture, go-to-market strategy, and cytometry
Investing in Early-Stage Companies Innovating at the Intersection of Biology and Technology.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 10 Sep 2024 | | |
Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 14 Dec 2021 | |